Skip To Main Content
Yin Lou on Muck Rack

Yin Lou

As seen in: Nature, arXiv, Genetic Engineering & Biotechnology News, The Journal of Clinical Investigation
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yin

Contact Yin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Comparative assessing prefabricated and conventional 3D morphology carbon emission intensity of economy chain hotel buildings in Hangzhou

|
By Dongyu Liu, Pengcheng Du, Qian Wu, Lena Tran, Yin Lou, Wenwen Shi, Gangwei Cai, Weijun Gao
| Nature Verified
Abstract Understanding the influence of building morphology on carbon emissions is essential for developing effective low-carbon strategies in the hospitality sector. This study investigates the carbon emission intensity (CEI) of 200 economy chain hotels in Hangzhou, China, constructed using comparative both prefabricated and conventional methods, from a three-dimensional morphological perspective.
Open in Who Shared Issue with article?

[2311.00964] On Finding Bi-objective Pareto-optimal Fraud Prevention Rule Sets for Fintech Applications

|
By Yin Lou
| arXiv
[Submitted on 2 Nov 2023 ( v1 ), last revised 27 Jun 2024 (this version, v3)] Title:On Finding Bi-objective Pareto-optimal Fraud Prevention Rule Sets for Fintech Applications View a PDF of the paper titled On Finding Bi-objective Pareto-optimal Fraud Prevention Rule Sets for Fintech Applications, by Chengyao Wen and 1 other authors View PDF HTML (experimental) Abstract:Rules are widely used in Fintech institutions to make fraud prevention decisions, since rules are highly interpretable thanks...
Open in Who Shared Issue with article?

Screening and Identification of Key Biomarkers in Melanoma

|
By Yijun Xia, Juan Xie, Jun Zhao, Yin Lou
| Genetic Engineering & Biotechnology News Verified
Malignant melanoma is uncommon worldwide, accounting for only ∼1% of all malignant tumors. However, it has the fastest growth rate among all malignant tumors, 3%–7% annually. Overall, malignant melanoma is an insidious disease with a high degree of malignancy. Surgery, radiotherapy, and chemotherapy have long been the main methods for the treatment of malignant melanoma.
Open in Who Shared Issue with article?
See all 3 articles